Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEPnews2023-05-09T17:34:57+00:00May 9th, 2023|The New York Times|
Johnson & Johnson Reaches Deal for $8.9 Billion Talc Settlementnews2023-04-05T01:25:02+00:00April 5th, 2023|The New York Times|
Biogen Agrees to Pay $900 Million to Settle Lawsuit Over Kickbacksnews2022-09-27T00:35:45+00:00September 27th, 2022|The New York Times|
CVS, Walgreens and Walmart Must Pay $650.5 Million in Ohio Opioids Casenews2022-08-17T21:04:19+00:00August 17th, 2022|The New York Times|
Teva Reaches Tentative $4.25 Billion Settlement Over Opioidsnews2022-07-26T22:26:32+00:00July 26th, 2022|The New York Times|
Companies Finalize $26 Billion Deal With States and Cities to End Opioid Lawsuitsnews2022-02-25T14:12:55+00:00February 25th, 2022|The New York Times|
Teva Pharmaceuticals Found Liable in Landmark Opioid Trialnews2021-12-30T23:06:33+00:00December 30th, 2021|The New York Times|
Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claimsnews2021-09-01T23:04:39+00:00September 1st, 2021|The New York Times|
Drug Companies to Pay N.Y. More Than $1 Billion to Settle Opioid Lawsuitnews2021-07-20T20:40:18+00:00July 20th, 2021|The New York Times|
15 States Reach a Deal With Purdue Pharma Over Opioidsnews2021-07-08T20:04:22+00:00July 8th, 2021|The New York Times|
